Movement Disorders

  • Stanley Fahn
  • Paul E. Greene
  • Blair Ford
  • Susan B. Bressman


Movement disorders can be defined as neurologic syndromes in which there is either an excess of movement (commonly referred to as hyperkinesia, dyskinesia, and abnormal involuntary movement), or a paucity of voluntary and automatic movements unrelated to weakness or spasticity. The latter group can be referred to as hypokinesia (decreased amplitude of movement), but bradykinesia (slowness of movement) and akinesia (loss of movement) are common alternatives. The parkinsonian syndromes are the most common cause of paucity of movement; other hypokinetic disorders represent only a small group of patients. Basically, movement disorders are conveniently divided into parkinsonism and all other types. Gait is affected by most types of movement disorders, including parkinsonism, dystonia, chorea, myoclonus, and cerebellar ataxia.


Movement Disorder Multiple System Atrophy Progressive Supranuclear Palsy Essential Tremor Normal Pressure Hydrocephalus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiat 1992, 55: 181–184.PubMedCrossRefGoogle Scholar
  2. 2.
    Wichmann T, DeLong MR: Pathophysiology of parkinsonian motor abnormali ties. Adv Neurol 1993, 60: 53–61.PubMedGoogle Scholar
  3. 3.
    Duvoisin RC, Eldridge R, Williams A, et al.: Twin study of Parkinson disease. Neurology 1981, 31:77–80.Google Scholar
  4. 4.
    Chase, TN, Mouradian MM, Engber TM: Motor response complications and the function of striatal efferent systems. Neurology 1993, 43 (suppl 6): S23 - S27.PubMedGoogle Scholar
  5. 5.
    Mouradian MM, Juncos JL, Fabbrini G, et al.: Motor fluctuations in Parkinson’s disease: central pathophysiological mechanisms, part II. Ann Neurol 1988, 24:372–378.Google Scholar
  6. 6.
    Laitinen LV, Bergenheim AT, Hariz MI: Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J Neurosurg 1992, 76: 53–61.PubMedCrossRefGoogle Scholar
  7. 7.
    Limousin P, Krack P, Pollak P, et al.: Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 1998, 339:1105–1111.Google Scholar
  8. 8.
    Steele RC, Richardson JC, Olszewski J: Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964, 10: 333–359.PubMedCrossRefGoogle Scholar
  9. 9.
    Lepore FE, Duvoisin RC: “Apraxia” of eyelid opening: an involuntary levator inhibition. Neurology 1985, 35: 423–427.PubMedCrossRefGoogle Scholar
  10. 10.
    Lantos PL: The Neuropathology of Progressive Supranuclear Palsy. In Progressive Supranuclear Palsy: Diagnosis, Pathology and Therapy. Edited by Tolosa E, Duvoisin R, Cruz-Sanchez FE New York: Springer-Verlag, Wein; 1994: 137–152.CrossRefGoogle Scholar
  11. 11.
    Brooks DJ: PET Studies in Progressive Supranuclear Palsy. In Progressive Supranuclear Palsy: Diagnosis, Pathology, and Therapy. Edited by Toloso E, Duvoisin R, Cruz-Sanchez FF. New York: Springer-Verlag; 1994: 119–132.CrossRefGoogle Scholar
  12. 11.
    Graham JG, Oppenheimer DR: Orthostatic hypotension and nicotinic sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969, 32: 28–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Lantos PL, Papp MI: Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994, 57: 129–133.PubMedCrossRefGoogle Scholar
  14. 14.
    Gilman S, Koeppe RA, Junck L, et al.: Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 1994, 36:166–175.Google Scholar
  15. 15.
    Rutledge JN, Schallert T, Hall S: Magnetic resonance imaging in parkinsonisms. Adv Neurol 1993, 60: 529–534.PubMedGoogle Scholar
  16. 16.
    Rebeiz JJ, Kolodny EH, Richardson EP Jr: Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968, 18: 20–33.PubMedCrossRefGoogle Scholar
  17. 17.
    Uchihara T, Mitani K, Mori H, et al.: Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer’s disease or progressive supranuclear palsy. Acta Neuropathol 1994, 88:379–383.Google Scholar
  18. 18.
    Klawans HL: Hemiparkinsonism as a late complication of hemiatrophy: a new syndrome. Neurology 1981, 31: 625–628.PubMedCrossRefGoogle Scholar
  19. 19.
    Perry RH, Irving D, Blessed G, et al.: Senile dementia of Lewy body type. J Neurol Sci 1990, 95:119–139.Google Scholar
  20. 20.
    Hakim S, Adams RD: The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure: observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 1965, 2: 307–327.PubMedCrossRefGoogle Scholar
  21. 21.
    Greene PE, Kang UJ, Fahn S: Spread of symptoms in idiopathic torsion dystonia. Mov Disord 1995, 10: 143–152.PubMedCrossRefGoogle Scholar
  22. 22.
    Kramer PL, Heiman GA, Gasser T, et al.: The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet 1994, 55:468–475.Google Scholar
  23. 23.
    Rothwell JC, Obeso JA, Day BL, Marsden CD: Pathophysiology of dystonias. In Motor Control Mechanisms in Health and Disease. Edited by Desmedt JE. New York: Raven Press; 1983: 851–863.Google Scholar
  24. 24.
    Marsden, CD, Obeso JA, Zarranz JJ, Lang AE: The anatomical basis of symptomatic hemidystonia. Brain 1985, 108: 461–483.CrossRefGoogle Scholar
  25. 25.
    Zilber N, Korcyn AD, Kahana E, et al.: Inheritance of idiopathic torsion dystonia among Jews. J Med Genet 1984, 21:13–26.Google Scholar
  26. 26.
    Waddy HM, Fletcher NA, Harding AE, Marsden CD: A genetic study of idiopathic focal dystonias. Ann Neural 1991, 29: 320–324.CrossRefGoogle Scholar
  27. 27.
    Bressman SB, deLeon D, Brin MF, et al.: Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann Neurol 1989, 26:612–620.Google Scholar
  28. 28.
    Bressman SB, Sabatti C, Raymond D, et al.: The DYT1 phenotype and guidelines for diagnostic tsting. Neurology 2000, 54:1746–1752.Google Scholar
  29. 29.
    Holmgren G, Ozelius L, Forsgren L, et al: Adult-onset idiopathic torsion dystonia is excluded from the DYT1 region (9q34) in a Swedish family. J Neurol Neurosurg Psychiatry 1995, 59: 178–181.PubMedCrossRefGoogle Scholar
  30. 30.
    Bressman SB, Hunt AL, Heiman GA, et al.: Exclusion of the DYT1 locus in a non-Jewish family with early-onset dystonia. Mov Disord 1994, 9:626–632.Google Scholar
  31. 31.
    Leube B, Rudnicki D, Ratzlaff T, et al.: Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet 1996, 5:1673–1677.Google Scholar
  32. 32.
    Ichinose H, Ohye T, Takahashi E, et al: Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994, 8: 229–235.CrossRefGoogle Scholar
  33. 33.
    Nygaard TG, Waran SP, Levine RA, et al.: Dopa-responsive dystonia simulating cerebral palsy. Pediat Neurol 1994,11:236–240.Google Scholar
  34. 34.
    Bull PD, Thomas GR, Rommens JM, et al.: The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene [published erratum appears in Nat Genet 1994, 6(2):214]. Nat Genet 1993, 5:327–237.Google Scholar
  35. 35.
    Tanzi RE, Petrukhin K, Chernov I, et al.: The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Gen 1993, 5:344–350.Google Scholar
  36. 36.
    Thomas GR, Forbes JR, Roberts EA, et al.: The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995, 9:210–217.Google Scholar
  37. 37.
    Wiebers DO, Hollenhorst RW, Goldstein NP: The ophthalmologic manifestations of Wilson’s disease. Mayo Clin Proc 1977, 52: 409–416.PubMedGoogle Scholar
  38. 38.
    Higgins JJ, Patterson MC, Papadopoulos NM, et al.: Hypoprebetalipoproteinemia, acanthocytosis, retinitis-pigmentosa, and pallidal degeneration (HARP syndrome). Neurology 1992, 42:194–198.Google Scholar
  39. 39.
    Sethi KD, Adams RJ, Loring DW, Gammal TE: Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988, 24: 692–694.PubMedCrossRefGoogle Scholar
  40. 40.
    Feinberg TE, Cianci CD, Morrow JS, et al.: Diagnostic tests for choreoacanthocytosis. Neurology 1991, 41:1000–1006.Google Scholar
  41. 41.
    Rubio JP, Danek A, Stone C, et al.: Chorea-acanthocytosis: genetic linkage to chromosome 9q21. Am J Hum Genet 1997; 61:899–908.Google Scholar
  42. 42.
    Witt TN, Danek A, Hein MU, et al.: McLeod syndrome: a distinct form of neuroacanthocytosis. J Neurol 1992, 239:302–306.Google Scholar
  43. 43.
    Orrell RW, Amrolia PJ, Heald A, et al.: Acanthocytosis, retinitis pigmentosa, and pallidal degeneration: a report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome). Neurology 1995, 45:487–491.Google Scholar
  44. 44.
    Huntington’s Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993, 72: 971–983.Google Scholar
  45. 45.
    Albin RL, Tagle DA: Genetics and molecular biology of Huntington’s disease. Trends Neurosci 1995, 18: 11–14.PubMedCrossRefGoogle Scholar
  46. 46.
    Kremer B, Goldberg P, Andrew SE, et al.: A worldwide study of the Huntington’s disease mutation-the sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994, 330:1401–1406.Google Scholar
  47. 47.
    Bressman SB, Risch NJ: Genetics of Movement Disorders: Dystonia, Dopa-responsive Dystonia and Huntington’s Disease. In Movement and Allied Disorders in Childhood. Edited by Robertson MM, Eapen V. London: John Wiley and Sons; 1995: 327–356.Google Scholar
  48. 48.
    Myers RH, MacDonald ME, Koroshetew J, et al.: De novo expansion of a (CAG)n repeat in sporadic Huntington’s disease. Nat Genet 1993, 5:168–173.Google Scholar
  49. 49.
    Martin WRW, Calne DB: Imaging Techniques and Movement Disorders. In Movement Disorders. Edited by Marsden CD, Fahn S. Boston: Butterworth; 1987: 14–16.Google Scholar
  50. 50.
    Harris GJ, Pearlson GD, Peyser CE, et al.: Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington’s disease. Ann Neurol 1992,31:69–75.Google Scholar
  51. 51.
    DeLong MR: Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990, 13: 281–285.PubMedCrossRefGoogle Scholar
  52. 52.
    Pauls DL, Raymond CL, Stevenson JM, Leckman JF: A family study of Gilles de la Tourette syndrome. Am J Human Genet 1991, 43: 154–163.Google Scholar
  53. 53.
    Singer HS, Hahn IH, Krowiak E, et al.: Tourette’s syndrome: a neurochemical analysis of postmortem cortical brain tissue. Ann Neurol 1990, 27:443–446.Google Scholar
  54. 54.
    Obeso JA, Rothwell JC, Marsden CD: The neurophysiology of Tourette syndrome. Adv Neurol 1982, 35: 105–114.PubMedGoogle Scholar
  55. 55.
    Elble RJ: Mechanisms of Physiological Tremor and Relationship to Essential Tremor. In Handbook of Tremor Disorders. Edited by Findley LJ, Koller WC. New York: Marcel Dekker; 1995.Google Scholar
  56. 56.
    Vitek JL, Wichmann T, DeLong MR: Current Concepts of Basal Ganglia Neurophysiology Relative to Tremorgenesis. In Handbook of Tremor Disorders. Edited by Findley LJ, Koller WC. New York: Marcel Dekker; 1995: 37–50.Google Scholar
  57. 57.
    Louis ED, Ford B, Lee H, et al.: Diagnostic criteria for essential tremor: a population perspective. Arch Neural 1998, 55:222–227.Google Scholar
  58. 58.
    Caparros-Lefebvre D, Ruchoux MM, Blond S, et al.: Long-term thalamic stimulation in Parkinson’s disease. Neurology 1994, 44:1856–1860.Google Scholar
  59. 59.
    Bogousslaysky J, Maeder P, Regli F, Meuli R: Pure midbrain infarction: clinical syndromes, MRI, and etiologic patterns. Neurology 1994, 44: 2032–2040.CrossRefGoogle Scholar
  60. 60.
    Wall M: Brainstem Syndromes. In Neurology in Clinical Practice. Bradley WG, Daroff RB, Fenichel GM, Marsden CD. Boston: Butterworth-Heinemann; 1991: 347–362.Google Scholar
  61. 61.
    Weiner WJ, Lang AE: Movement Disorders: A Comprehensive Survey. Mount Kisco, NY: Futura; 1989: 457–530.Google Scholar
  62. 62.
    Carpenter MB: Core Text of Neuroanatomy, edn 3. Baltimore: Williams & Wilkins; 1985.Google Scholar
  63. 63.
    Shibasaki H, Kuriowa Y: Electroencephalographic correlates of myoclonus. Electroencephalog Clin Neurophysiol 1975, 39: 455–463.CrossRefGoogle Scholar
  64. 64.
    Shibasaki H, Yamashita Y, Kuriowa Y: Electroencephalographic studies of myoclonus; myoclonus-related cortical spikes and high amplitude somatasensory evoked potentials. Brain 1978, 101: 447–460.PubMedCrossRefGoogle Scholar
  65. 65.
    Shibasaki H, Yamashita Y, Tobimatsu S, Neshige R: Electroencephalographic correlates of myoclonus. In Adv Neurol 1986, 43: 357–372.PubMedGoogle Scholar
  66. 66.
    Young RH, Shahani BT: Asterixis: one type of negative myoclonus. Adv Neurol 1986, 43: 137–156.PubMedGoogle Scholar
  67. 67.
    Kang UJ, Burke RE, Fahn S: Natural history and treatment of tardive dystonia. Mov Disord 1986, 1: 193–208.PubMedCrossRefGoogle Scholar
  68. 68.
    Barker FG, Jannetta PJ, Bissonette DJ, et al.: Microvascular compression for hemifacial spasm. J Neurosurg 1995, 82:201–210.Google Scholar
  69. 69.
    Jannetta PJ: Cranial Rhizotomies. In Neurological Surgery. Edited by Youmans JR. vol 6, edn 3. Philadelphia: WB Saunders; 1990, 4169–4182.Google Scholar
  70. 70.
    Williams DT, Ford B, Fahn S: Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neural 1995, 65: 231–257.Google Scholar
  71. 71.
    Fahn S: Paroxysmal Dyskinesias. In Movement Disorders III. Edited by Marsden CD, Fahn S. Oxford: Butterworth-Heinemann; 1994: 310–345.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Stanley Fahn
  • Paul E. Greene
  • Blair Ford
  • Susan B. Bressman

There are no affiliations available

Personalised recommendations